Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells

References

• Weiss B, Bollag G, Shannon K. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Am J Med Genet 1999; 89:14 - 22; http://dx.doi.org/10.1002/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.0.CO;2-4; PMID: 10469432
   PubMed Web of Science ®Google Scholar
• Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990; 63:851 - 9; http://dx.doi.org/10.1016/0092-8674(90)90151-4; PMID: 2121371
   PubMed Web of Science ®Google Scholar
• Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O’Connell P, Cawthon RM, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990; 63:843 - 9; http://dx.doi.org/10.1016/0092-8674(90)90150-D; PMID: 2121370
   PubMed Web of Science ®Google Scholar
• Xu GF, O’Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62:599 - 608; http://dx.doi.org/10.1016/0092-8674(90)90024-9; PMID: 2116237
   PubMed Web of Science ®Google Scholar
• Thomas L, Richards M, Mort M, Dunlop E, Cooper DN, Upadhyaya M. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene. Hum Mutat 2012; 33:1687 - 96; http://dx.doi.org/10.1002/humu.22162; PMID: 22807134
   PubMed Web of Science ®Google Scholar
• Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992; 356:713 - 5; http://dx.doi.org/10.1038/356713a0; PMID: 1570015
   PubMed Web of Science ®Google Scholar
• DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 1992; 69:265 - 73; http://dx.doi.org/10.1016/0092-8674(92)90407-4; PMID: 1568246
   PubMed Web of Science ®Google Scholar
• Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996; 12:144 - 8; http://dx.doi.org/10.1038/ng0296-144; PMID: 8563751
   PubMed Web of Science ®Google Scholar
• Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001; 104:593 - 604; http://dx.doi.org/10.1016/S0092-8674(01)00245-8; PMID: 11239415
   PubMed Web of Science ®Google Scholar
• Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004; 17:101 - 5; http://dx.doi.org/10.1097/00019052-200404000-00004; PMID: 15021234
   PubMed Web of Science ®Google Scholar
• Gottfried ON, Viskochil DH, Fults DW, Couldwell WT. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 2006; 58:1 - 16, discussion 1-16; http://dx.doi.org/10.1227/01.NEU.0000190651.45384.8B; PMID: 16385324
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Parada LF, Silva AJ, Ratner N. Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci 2012; 32:14087 - 93; http://dx.doi.org/10.1523/JNEUROSCI.3242-12.2012; PMID: 23055477
   PubMed Web of Science ®Google Scholar
• Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999; 89:1 - 6; http://dx.doi.org/10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8; PMID: 10469430
   PubMed Web of Science ®Google Scholar
• Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005; 65:1037 - 44; http://dx.doi.org/10.1212/01.wnl.0000179303.72345.ce; PMID: 16217056
   PubMed Web of Science ®Google Scholar
• Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Evans DG, et al. Neurofibromatosis 2011: a report of the children’s tumor foundation annual meeting. 2012; Acta Neuropathol: 123: 369-80.
   Google Scholar
• Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9:484 - 96; PMID: 7737456
   PubMed Web of Science ®Google Scholar
• Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004; 5:785 - 90; http://dx.doi.org/10.1038/ni1097; PMID: 15282562
   PubMed Web of Science ®Google Scholar
• Reyland ME. Protein kinase C isoforms: Multi-functional regulators of cell life and death. Front Biosci (Landmark Ed) 2009; 14:2386 - 99; http://dx.doi.org/10.2741/3385; PMID: 19273207
   PubMed Web of Science ®Google Scholar
• Zhu T, Tsuji T, Chen C. Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras. Oncogene 2010; 29:1050 - 61; http://dx.doi.org/10.1038/onc.2009.344; PMID: 19838205
   PubMed Web of Science ®Google Scholar
• Zhu T, Chen L, Du W, Tsuji T, Chen C. Synthetic lethality induced by loss of PKC delta and mutated Ras. Genes Cancer 2010; 1:142 - 51; http://dx.doi.org/10.1177/1947601909360989; PMID: 21031151
   PubMedGoogle Scholar
• Shen L, Kim SH, Chen CY. Sensitization of human pancreatic cancer cells harboring mutated K-ras to apoptosis. PLoS One 2012; 7:e40435; http://dx.doi.org/10.1371/journal.pone.0040435; PMID: 22848379
   PubMedGoogle Scholar
• McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, et al. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell 2009; 16:44 - 54; http://dx.doi.org/10.1016/j.ccr.2009.05.009; PMID: 19573811
   PubMed Web of Science ®Google Scholar
• Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835 - 48; http://dx.doi.org/10.1016/j.cell.2009.05.006; PMID: 19490893
   PubMed Web of Science ®Google Scholar
• Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408:433 - 9; http://dx.doi.org/10.1038/35044005; PMID: 11100718
   PubMed Web of Science ®Google Scholar
• Reinhardt HC, Yaffe MB. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 2009; 21:245 - 55; http://dx.doi.org/10.1016/j.ceb.2009.01.018; PMID: 19230643
   PubMed Web of Science ®Google Scholar
• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179 - 204; http://dx.doi.org/10.1016/j.molcel.2010.09.019; PMID: 20965415
   PubMed Web of Science ®Google Scholar
• Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011; 12:385 - 92; http://dx.doi.org/10.1038/nrm3115; PMID: 21527953
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 2007; 6:70 - 4; http://dx.doi.org/10.4161/cc.6.1.3682; PMID: 17245109
   PubMed Web of Science ®Google Scholar
• Booher R, Beach D. Involvement of a type 1 protein phosphatase encoded by bws1+ in fission yeast mitotic control. Cell 1989; 57:1009 - 16; http://dx.doi.org/10.1016/0092-8674(89)90339-5; PMID: 2544292
   PubMed Web of Science ®Google Scholar
• Löffler H, Rebacz B, Ho AD, Lukas J, Bartek J, Krämer A. Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events. Cell Cycle 2006; 5:2543 - 7; PMID: 17106257
   PubMed Web of Science ®Google Scholar
• Jensen S, Johnston LH. Complexity of mitotic exit. Cell Cycle 2002; 1:300 - 3; http://dx.doi.org/10.4161/cc.1.5.142; PMID: 12461287
   PubMed Web of Science ®Google Scholar
• Dumitrescu TP, Saunders WS. The FEAR Before MEN: networks of mitotic exit. Cell Cycle 2002; 1:304 - 7; http://dx.doi.org/10.4161/cc.1.5.147; PMID: 12461288
   PubMed Web of Science ®Google Scholar
• Lee TH, Kirschner MW. An inhibitor of p34cdc2/cyclin B that regulates the G2/M transition in Xenopus extracts. Proc Natl Acad Sci U S A 1996; 93:352 - 6; http://dx.doi.org/10.1073/pnas.93.1.352; PMID: 8552637
   PubMed Web of Science ®Google Scholar
• Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nat Rev Mol Cell Biol 2007; 8:894 - 903; http://dx.doi.org/10.1038/nrm2276; PMID: 17912263
   PubMed Web of Science ®Google Scholar
• Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23:2825 - 37; http://dx.doi.org/10.1038/sj.onc.1207528; PMID: 15077146
   PubMed Web of Science ®Google Scholar
• Eriksson D, Löfroth PO, Johansson L, Riklund KA, Stigbrand T. Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Clin Cancer Res 2007; 13:5501s - 8s; http://dx.doi.org/10.1158/1078-0432.CCR-07-0980; PMID: 17875782
   PubMed Web of Science ®Google Scholar
• Piwnica-Worms H. Reversible phosphorylation and mitotic control. J Lab Clin Med 1996; 128:350 - 4; http://dx.doi.org/10.1016/S0022-2143(96)80005-9; PMID: 8833882
   PubMed Web of Science ®Google Scholar
• Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277:1497 - 501; http://dx.doi.org/10.1126/science.277.5331.1497; PMID: 9278511
   PubMed Web of Science ®Google Scholar
• Huang X, Tran T, Zhang L, Hatcher R, Zhang P. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci U S A 2005; 102:1065 - 70; http://dx.doi.org/10.1073/pnas.0409130102; PMID: 15650047
   PubMed Web of Science ®Google Scholar
• Sandsmark DK, Zhang H, Hegedus B, Pelletier CL, Weber JD, Gutmann DH. Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes. Cancer Res 2007; 67:4790 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-4470; PMID: 17510408
   PubMed Web of Science ®Google Scholar
• Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994; 8:1019 - 29; http://dx.doi.org/10.1101/gad.8.9.1019; PMID: 7926784
   PubMed Web of Science ®Google Scholar
• Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, Karp J, Bockenstedt P, et al. NF1 inactivation in adult acute myelogenous leukemia. Clin Cancer Res 2010; 16:4135 - 47; http://dx.doi.org/10.1158/1078-0432.CCR-09-2639; PMID: 20505189
   PubMed Web of Science ®Google Scholar
• Bottillo I, Ahlquist T, Brekke H, Danielsen SA, van den Berg E, Mertens F, Lothe RA, Dallapiccola B. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. J Pathol 2009; 217:693 - 701; http://dx.doi.org/10.1002/path.2494; PMID: 19142971
   PubMed Web of Science ®Google Scholar
• Beert E, Brems H, Daniëls B, De Wever I, Van Calenbergh F, Schoenaers J, Debiec-Rychter M, Gevaert O, De Raedt T, Van Den Bruel A, et al. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes Chromosomes Cancer 2011; 50:1021 - 32; http://dx.doi.org/10.1002/gcc.20921; PMID: 21987445
   PubMed Web of Science ®Google Scholar
• Patel AV, Eaves D, Jessen WJ, Rizvi TA, Ecsedy JA, Qian MG, Aronow BJ, Perentesis JP, Serra E, Cripe TP, et al. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. Clin Cancer Res 2012; 18:5020 - 30; http://dx.doi.org/10.1158/1078-0432.CCR-12-1072; PMID: 22811580
   PubMed Web of Science ®Google Scholar
• Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M, Philips MR. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008; 181:485 - 96; http://dx.doi.org/10.1083/jcb.200801047; PMID: 18443222
   PubMed Web of Science ®Google Scholar
• Tinker-Kulberg RL, Morgan DO. Pds1 and Esp1 control both anaphase and mitotic exit in normal cells and after DNA damage. Genes Dev 1999; 13:1936 - 49; http://dx.doi.org/10.1101/gad.13.15.1936; PMID: 10444592
   PubMed Web of Science ®Google Scholar
• Cooper JA, Nelson SA. Checkpoint control of mitotic exit--do budding yeast mind the GAP?. J Cell Biol 2006; 172:331 - 3; http://dx.doi.org/10.1083/jcb.200512153; PMID: 16431930
   PubMed Web of Science ®Google Scholar
• Barboule N, Lafon C, Chadebech P, Vidal S, Valette A. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett 1999; 444:32 - 7; http://dx.doi.org/10.1016/S0014-5793(99)00022-8; PMID: 10037143
   PubMed Web of Science ®Google Scholar
• Besson A, Yong VW. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol 2000; 20:4580 - 90; http://dx.doi.org/10.1128/MCB.20.13.4580-4590.2000; PMID: 10848585
   PubMed Web of Science ®Google Scholar
• Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C. Interaction between protein kinase C and actin in megakaryocyte polyploidization. Anticancer Res 1999; 19:5B 4193 - 8; PMID: 10628374
   PubMedGoogle Scholar
• Williams CM, Harper MT, Poole AW. PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice. Platelets 2014; 25:62 - 8; http://dx.doi.org/10.3109/09537104.2012.761686; PMID: 23402219
   PubMed Web of Science ®Google Scholar